Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer

被引：15

作者：

Basu, Sandip

Alavi, Abass

机构：

[1] Hosp Univ Penn, Div Nucl Med, Philadelphia, PA 19104 USA

[2] Tata Mem Ctr Annexe, Radiat Med Ctr BARC, Bombay, Maharashtra, India

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷 / 01期

关键词：

D O I：

10.1007/s00259-007-0506-2

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：1 / 4

页数：4

共 36 条

[1] Finding infection - help from PET [J].

Alavi, A ;

Zhuang, HM .

LANCET, 2001, 358 (9291) :1386-1386

[2]

Basu S, 2007, J CLIN ONCOL, V25, P1297, DOI 10.1200/JCO.2006.10.0123

[3] Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites? [J].

Basu, Sandip ;

Alavi, Abass .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) :604-605

[4] Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation [J].

Becherer, A ;

Mitterbauer, M ;

Jaeger, U ;

Kalhs, P ;

Greinix, HT ;

Karanikas, G ;

Pötzi, C ;

Raderer, M ;

Dudczak, R ;

Kletter, K .

LEUKEMIA, 2002, 16 (02) :260-267

[5] Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy [J].

Becker, Sven ;

Becker-Pergola, Graziella ;

Wallwiener, Diethelm ;

Solomayer, Erich-Franz ;

Fehm, Tanja .

BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (01) :91-96

[6] The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment [J].

Bombardieri, Emilio .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (07) :753-758

[7]

Brücher BLDM, 2001, ANN SURG, V233, P300

[8] Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial [J].

Burmeister, BH ;

Smithers, BM ;

Gebski, V ;

Fitzgerald, L ;

Simes, RJ ;

Devitt, P ;

Ackland, S ;

Gotley, DC ;

Joseph, D ;

Millar, J ;

North, J ;

Walpole, ET ;

Denham, JW .

LANCET ONCOLOGY, 2005, 6 (09) :659-668

[9]

Couper GW, 1998, BRIT J SURG, V85, P1403

[10] 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma [J].

de Wit, M ;

Bohuslavizki, KH ;

Buchert, R ;

Bumann, D ;

Clausen, M ;

Hossfeld, DK .

ANNALS OF ONCOLOGY, 2001, 12 (01) :29-37

← 1 2 3 4 →